Speech therapy for children with rare genetic conditions and speech apraxia
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This trial tests a speech therapy program for children with rare genetic conditions who also have childhood apraxia of speech, a disorder where the brain has trouble planning the movements needed for speech. The therapy is intensive—three sessions a week for four weeks—and may help improve your child's ability to speak clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 3 and 16 years old
- Your child has a confirmed genetic condition
- Your child has been diagnosed with childhood apraxia of speech
- English is the primary language spoken at home
- Your child can participate in speech therapy three times a week for four weeks
- Your child does not have an acquired brain injury or movement condition that affects speech
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a motor-based speech therapy program for children with childhood apraxia of speech (CAS), a motor speech disorder that makes it hard to plan and coordinate the movements needed for speech. The study may help improve your child's speaking skills.
This trial tests a new speech therapy method that uses ultrasound to show children a live picture of their tongue movements on a screen. It aims to help children with childhood apraxia of speech improve their speech by giving them visual feedback as they practice sounds.
This study tests an omega-3 supplement (called Omega-DEK) to see if it helps improve speech in children with childhood apraxia of speech, a motor speech disorder. It is a randomized trial, meaning some children will get the supplement and others will get a placebo (a dummy), and neither you nor the researchers will know which one your child receives.
This study tests whether a speech-generating tablet (like an iPad with a communication app) can help children with rare genetic conditions who are minimally verbal (using fewer than 50 words) to communicate better. If your child fits the criteria, they could get a device and training to see if it helps them express themselves more easily.
This study tests a speech treatment plan for children on the autism spectrum who currently speak very little. It aims to improve speech clarity and ability to repeat sounds, but only if the child’s home language environment and participation needs fit the study rules.
This early-stage trial tests an intensive speech-therapy approach to help kids who have trouble saying the sounds “r” and/or “s.” It may help improve how clearly your child’s speech sounds and how confidently they speak.
Hear when a new Childhood Apraxia of Speech trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.